Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

Global Retinoblastoma Presentation and Analysis by National Income Level.

Global Retinoblastoma Study Group, Fabian ID, Abdallah E, Abdullahi SU, Abdulqader RA, Adamou Boubacar S, Ademola-Popoola DS, Adio A, Afshar AR, Aggarwal P, Aghaji AE, Ahmad A, Akib MNR, Al Harby L, Al Ani MH, Alakbarova A, Portabella SA, Al-Badri SAF, Alcasabas APA, Al-Dahmash SA, Alejos A, Alemany-Rubio E, Alfa Bio AI, Alfonso Carreras Y, Al-Haddad C, Al-Hussaini HHY, Ali AM, Alia DB, Al-Jadiry MF, Al-Jumaly U, Alkatan HM, All-Eriksson C, Al-Mafrachi AARM, Almeida AA, Alsawidi KM, Al-Shaheen AASM, Al-Shammary EH, Amiruddin PO, Antonino R, Astbury NJ, Atalay HT, Atchaneeyasakul LO, Atsiaya R, Attaseth T, Aung TH, Ayala S, Baizakova B, Balaguer J, Balayeva R, Balwierz W, Barranco H, Bascaran C, Beck Popovic M, Benavides R, Benmiloud S, Bennani Guebessi N, Berete RC, Berry JL, Bhaduri A, Bhat S, Biddulph SJ, Biewald EM, Bobrova N, Boehme M, Boldt HC, Bonanomi MTBC, Bornfeld N, Bouda GC, Bouguila H, Boumedane A, Brennan RC, Brichard BG, Buaboonnam J, Calderón-Sotelo P, Calle Jara DA, Camuglia JE, Cano MR, Capra M, Cassoux N, Castela G, Castillo L, Català-Mora J, Chantada GL, Chaudhry S, Chaugule SS, Chauhan A, Chawla B, Chernodrinska VS, Chiwanga FS, Chuluunbat T, Cieslik K, Cockcroft RL, Comsa C, Correa ZM, Correa Llano MG, Corson TW, Cowan-Lyn KE, Csóka M, Cui X, Da Gama IV, Dangboon W, Das A, Das S, Davanzo JM, Davidson A, De Potter P, Delgado KQ, Demirci H, Desjardins L, Diaz Coronado RY, Dimaras H, Dodgshun AJ, Donaldson C, Donato Macedo CR, Dragomir MD, Du Y, Du Bruyn M, Edison KS, Eka Sutyawan IW, El Kettani A, Elbahi AM, Elder JE, Elgalaly D, Elhaddad AM, Elhassan MMA, Elzembely MM, Essuman VA, Evina TGA, Fadoo Z, Fandiño AC, Faranoush M, Fasina O, Fernández DDPG, Fernández-Teijeiro A, Foster A, Frenkel S, Fu LD, Fuentes-Alabi SL, Gallie BL, Gandiwa M, Garcia JL, García Aldana D, Gassant PY, Geel JA, Ghassemi F, Girón AV, Gizachew Z, Goenz MA, Gold AS, Goldberg-Lavid M, Gole GA, Gomel N, Gonzalez E, Gonzalez Perez G, González-Rodríguez L, Garcia Pacheco HN, Graells J, Green L, Gregersen PA, Grigorovski NDAK, Guedenon KM, Gunasekera DS, Gündüz AK, Gupta H, Gupta S, Hadjistilianou T, Hamel P, Hamid SA, Hamzah N, Hansen ED, Harbour JW, Hartnett ME, Hasanreisoglu M, Hassan S, Hassan S, Hederova S, Hernandez J, Hernandez LMC, Hessissen L, Hordofa DF, Huang LC, Hubbard GB, Hummlen M, Husakova K, Hussein Al-Janabi AN, Ida R, Ilic VR, Jairaj V, Jeeva I, Jenkinson H, Ji X, Jo DH, Johnson KP, Johnson WJ, Jones MM, Kabesha TBA, Kabore RL, Kaliki S, Kalinaki A, Kantar M, Kao LY, Kardava T, Kebudi R, Kepak T, Keren-Froim N, Khan ZJ, Khaqan HA, Khauv P, Kheir WJ, Khetan V, Khodabande A, Khotenashvili Z, Kim JW, Kim JH, Kiratli H, Kivelä TT, Klett A, Komba Palet JEK, Krivaitiene D, Kruger M, Kulvichit K, Kuntorini MW, Kyara A, Lachmann ES, Lam CPS, Lam GC, Larson SA, Latinovic S, Laurenti KD, Le BHA, Lecuona K, Leverant AA, Li C, Limbu B, Long QB, López JP, Lukamba RM, Lumbroso L, Luna-Fineman S, Lutfi D, Lysytsia L, Magrath GN, Mahajan A, Majeed AR, Maka E, Makan M, Makimbetov EK, Manda C, Martín Begue N, Mason L, Mason JO 3rd, Matende IO, Materin M, Mattosinho CCDS, Matua M, Mayet I, Mbumba FB, McKenzie JD, Medina-Sanson A, Mehrvar A, Mengesha AA, Menon V, Mercado GJVD, Mets MB, Midena E, Mishra DKC, Mndeme FG, Mohamedani AA, Mohammad MT, Moll AC, Montero MM, Morales RA, Moreira C, Mruthyunjaya P, Msina MS, Msukwa G, Mudaliar SS, Muma KI, Munier FL, Murgoi G, Murray TG, Musa KO, Mushtaq A, Mustak H, Muyen OM, Naidu G, Nair AG, Naumenko L, Ndoye Roth PA, Nency YM, Neroev V, Ngo H, Nieves RM, Nikitovic M, Nkanga ED, Nkumbe H, Nuruddin M, Nyaywa M, Obono-Obiang G, Oguego NC, Olechowski A, Oliver SCN, Osei-Bonsu P, Ossandon D, Paez-Escamilla MA, Pagarra H, Painter SL, Paintsil V, Paiva L, Pal BP, Palanivelu MS, Papyan R, Parrozzani R, Parulekar M, Pascual Morales CR, Paton KE, Pawinska-Wasikowska K, Pe'er J, Peña A, Peric S, Pham CTM, Philbert R, Plager DA, Pochop P, Polania RA, Polyakov VG, Pompe MT, Pons JJ, Prat D, Prom V, Purwanto I, Qadir AO, Qayyum S, Qian J, Rahman A, Rahman S, Rahmat J, Rajkarnikar P, Ramanjulu R, Ramasubramanian A, Ramirez-Ortiz MA, Raobela L, Rashid R, Reddy MA, Reich E, Renner LA, Reynders D, Ribadu D, Riheia MM, Ritter-Sovinz P, Rojanaporn D, Romero L, Roy SR, Saab RH, Saakyan S, Sabhan AH, Sagoo MS, Said AMA, Saiju R, Salas B, San Román Pacheco S, Sánchez GL, Sayalith P, Scanlan TA, Schefler AC, Schoeman J, Sedaghat A, Seregard S, Seth R, Shah AS, Shakoor SA, Sharma MK, Sherief ST, Shetye NG, Shields CL, Siddiqui SN, Sidi Cheikh S, Silva S, Singh AD, Singh N, Singh U, Singha P, Sitorus RS, Skalet AH, Soebagjo HD, Sorochynska T, Ssali G, Stacey AW, Staffieri SE, Stahl ED, Stathopoulos C, Stirn Kranjc B, Stones DK, Strahlendorf C, Suarez MEC, Sultana S, Sun X, Sundy M, Superstein R, Supriyadi E, Surukrattanaskul S, Suzuki S, Svojgr K, Sylla F, Tamamyan G, Tan D, Tandili A, Tarrillo Leiva FF, Tashvighi M, Tateshi B, Tehuteru ES, Teixeira LF, Teh KH, Theophile T, Toledano H, Trang DL, Traoré F, Trichaiyaporn S, Tuncer S, Tyau-Tyau H, Umar AB, Unal E, Uner OE, Urbak SF, Ushakova TL, Usmanov RH, Valeina S, van Hoefen Wijsard M, Varadisai A, Vasquez L, Vaughan LO, Veleva-Krasteva NV, Verma N, Victor AA, Viksnins M, Villacís Chafla EG, Vishnevskia-Dai V, Vora T, Wachtel AE, Wackernagel W, Waddell K, Wade PD, Wali AH, Wang YZ, Weiss A, Wilson MW, Wime ADC, Wiwatwongwana A, Wiwatwongwana D, Wolley Dod C, Wongwai P, Xiang D, Xiao Y, Yam JC, Yang H, Yanga JM, Yaqub MA, Yarovaya VA, Yarovoy AA, Ye H, Yousef YA, Yuliawati P, Zapata López AM, Zein E, Zhang C, Zhang Y, Zhao J, Zheng X, Zhilyaeva K, Zia N, Ziko OAO, Zondervan M, Bowman R.

JAMA Oncol. 2020 Feb 27. doi: 10.1001/jamaoncol.2019.6716. [Epub ahead of print]

2.

Single-cell analysis of olfactory neurogenesis and differentiation in adult humans.

Durante MA, Kurtenbach S, Sargi ZB, Harbour JW, Choi R, Kurtenbach S, Goss GM, Matsunami H, Goldstein BJ.

Nat Neurosci. 2020 Mar;23(3):323-326. doi: 10.1038/s41593-020-0587-9. Epub 2020 Feb 17.

PMID:
32066986
3.

Influence of tumor shape and location in eye plaque brachytherapy dosimetry.

Studenski MT, Patel NV, Markoe A, Harbour JW, Samuels SE.

Brachytherapy. 2020 Mar - Apr;19(2):249-254. doi: 10.1016/j.brachy.2020.01.001. Epub 2020 Feb 13.

PMID:
32061535
4.

Single-cell analysis reveals new evolutionary complexity in uveal melanoma.

Durante MA, Rodriguez DA, Kurtenbach S, Kuznetsov JN, Sanchez MI, Decatur CL, Snyder H, Feun LG, Livingstone AS, Harbour JW.

Nat Commun. 2020 Jan 24;11(1):496. doi: 10.1038/s41467-019-14256-1.

5.

Decitabine limits escape from MEK inhibition in uveal melanoma.

Gonçalves J, Emmons MF, Faião-Flores F, Aplin AE, Harbour JW, Licht JD, Wink MR, Smalley KSM.

Pigment Cell Melanoma Res. 2019 Nov 23. doi: 10.1111/pcmr.12849. [Epub ahead of print]

PMID:
31758842
6.

Intraocular Dissemination of Uveal Melanoma Cells Following Radiotherapy: Evolving Management Over the Past Decade.

Paez-Escamilla M, Walter SD, Mohsenin A, Decatur CL, Harocopos GJ, Dubovy S, Harbour JW.

Ophthalmic Surg Lasers Imaging Retina. 2019 Sep 1;50(9):573-579. doi: 10.3928/23258160-20190905-06.

7.

Intraocular Metastasis in Unilateral Multifocal Uveal Melanoma Without Melanocytosis or Germline BAP1 Mutations.

Durante MA, Walter SD, Paez-Escamilla M, Tokarev J, Decatur CL, Dubovy SR, Schefler AC, Harbour JW.

JAMA Ophthalmol. 2019 Oct 3. doi: 10.1001/jamaophthalmol.2019.3941. [Epub ahead of print]

PMID:
31580399
8.

BAP1 regulates epigenetic switch from pluripotency to differentiation in developmental lineages giving rise to BAP1-mutant cancers.

Kuznetsov JN, Aguero TH, Owens DA, Kurtenbach S, Field MG, Durante MA, Rodriguez DA, King ML, Harbour JW.

Sci Adv. 2019 Sep 18;5(9):eaax1738. doi: 10.1126/sciadv.aax1738. eCollection 2019 Sep.

9.

Follow the nevus: the cost-utility of monitoring for growth of choroidal nevi.

Barsam AS, Gibbons A, McClellan AJ, Harbour JW, Smiddy WE.

Int J Ophthalmol. 2019 Sep 18;12(9):1456-1464. doi: 10.18240/ijo.2019.09.14. eCollection 2019.

10.

BAP1 Loss Is Associated with DNA Methylomic Repatterning in Highly Aggressive Class 2 Uveal Melanomas.

Field MG, Kuznetsov JN, Bussies PL, Cai LZ, Alawa KA, Decatur CL, Kurtenbach S, Harbour JW.

Clin Cancer Res. 2019 Sep 15;25(18):5663-5673. doi: 10.1158/1078-0432.CCR-19-0366. Epub 2019 Jul 8.

11.

HDAC Inhibition Enhances the In Vivo Efficacy of MEK Inhibitor Therapy in Uveal Melanoma.

Faião-Flores F, Emmons MF, Durante MA, Kinose F, Saha B, Fang B, Koomen JM, Chellappan SP, Maria-Engler SS, Rix U, Licht JD, Harbour JW, Smalley KSM.

Clin Cancer Res. 2019 Sep 15;25(18):5686-5701. doi: 10.1158/1078-0432.CCR-18-3382. Epub 2019 Jun 21.

12.

Integrative Copy Number Analysis of Uveal Melanoma Reveals Novel Candidate Genes Involved in Tumorigenesis Including a Tumor Suppressor Role for PHF10/BAF45a.

Anbunathan H, Verstraten R, Singh AD, Harbour JW, Bowcock AM.

Clin Cancer Res. 2019 Aug 15;25(16):5156-5166. doi: 10.1158/1078-0432.CCR-18-3052. Epub 2019 Jun 21.

13.

Genomic evolution of uveal melanoma arising in ocular melanocytosis.

Durante MA, Field MG, Sanchez MI, Covington KR, Decatur CL, Dubovy SR, Harbour JW.

Cold Spring Harb Mol Case Stud. 2019 Aug 1;5(4). pii: a004051. doi: 10.1101/mcs.a004051. Print 2019 Aug.

14.

Vitreoretinal lymphoma followed by systemic diffuse large B cell lymphoma.

Fan KC, Tran KD, Harbour JW, Dubovy SA, Patel NA, Albini TA.

J Ophthalmic Inflamm Infect. 2019 Jun 10;9(1):11. doi: 10.1186/s12348-019-0177-8.

15.

An Eight-Year-Old Girl Presents With Two Weeks of Vision Loss and Nightly Headaches.

Scott NL, Tran KD, Cernichiaro-Espinosa LA, Russell JF, Hinkle JW, Harbour JW, Dubovy SR, Berrocal AM.

Ophthalmic Surg Lasers Imaging Retina. 2019 May 1;50(5):314-317. doi: 10.3928/23258160-20190503-09.

PMID:
31100163
16.

Longitudinal Examination of Fellow-Eye Vascular Anomalies in Coats' Disease With Widefield Fluorescein Angiography: A Multicenter Study.

Jeng-Miller KW, Soomro T, Scott NL, Rao P, Marlow E, Chang EY, Ells A, Chau F, Nudleman E, Calvo CM, Patel N, Schwartz R, Cernichiaro-Espinosa LA, Montoya AG, Goldstein J, Harper CA 3rd, Baumal CR, Hartnett ME, Harbour JW, Besirli CG, Gupta MP, Chan RVP, Drenser KA, Capone A Jr, Murray TG, Mukai S, Trese MT, Berrocal AM, Wong SC, Yonekawa Y.

Ophthalmic Surg Lasers Imaging Retina. 2019 Apr 1;50(4):221-227. doi: 10.3928/23258160-20190401-04.

17.

Dosimetric comparison of circular Eye Physics and Collaborative Ocular Melanoma Study plaques to treat uveal melanoma.

Dean MK, Studenski MT, Paez-Escamilla MA, Walter SD, Kwon D, Markoe AM, Harbour JW, Samuels SE.

Brachytherapy. 2019 May - Jun;18(3):404-410. doi: 10.1016/j.brachy.2019.01.005. Epub 2019 Feb 20.

PMID:
30797699
18.

Bilateral radiation therapy followed by methotrexate-based chemotherapy for primary vitreoretinal lymphoma.

de la Fuente MI, Alderuccio JP, Reis IM, Omuro A, Markoe A, Echegaray JJ, Davis JL, Harbour JW, Lossos IS.

Am J Hematol. 2019 Apr;94(4):455-460. doi: 10.1002/ajh.25414. Epub 2019 Feb 4.

19.

Drug and disease signature integration identifies synergistic combinations in glioblastoma.

Stathias V, Jermakowicz AM, Maloof ME, Forlin M, Walters W, Suter RK, Durante MA, Williams SL, Harbour JW, Volmar CH, Lyons NJ, Wahlestedt C, Graham RM, Ivan ME, Komotar RJ, Sarkaria JN, Subramanian A, Golub TR, Schürer SC, Ayad NG.

Nat Commun. 2018 Dec 14;9(1):5315. doi: 10.1038/s41467-018-07659-z.

20.

Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.

Walpole S, Pritchard AL, Cebulla CM, Pilarski R, Stautberg M, Davidorf FH, de la Fouchardière A, Cabaret O, Golmard L, Stoppa-Lyonnet D, Garfield E, Njauw CN, Cheung M, Turunen JA, Repo P, Järvinen RS, van Doorn R, Jager MJ, Luyten GPM, Marinkovic M, Chau C, Potrony M, Höiom V, Helgadottir H, Pastorino L, Bruno W, Andreotti V, Dalmasso B, Ciccarese G, Queirolo P, Mastracci L, Wadt K, Kiilgaard JF, Speicher MR, van Poppelen N, Kilic E, Al-Jamal RT, Dianzani I, Betti M, Bergmann C, Santagata S, Dahiya S, Taibjee S, Burke J, Poplawski N, O'Shea SJ, Newton-Bishop J, Adlard J, Adams DJ, Lane AM, Kim I, Klebe S, Racher H, Harbour JW, Nickerson ML, Murali R, Palmer JM, Howlie M, Symmons J, Hamilton H, Warrier S, Glasson W, Johansson P, Robles-Espinoza CD, Ossio R, de Klein A, Puig S, Ghiorzo P, Nielsen M, Kivelä TT, Tsao H, Testa JR, Gerami P, Stern MH, Paillerets BB, Abdel-Rahman MH, Hayward NK.

J Natl Cancer Inst. 2018 Dec 1;110(12):1328-1341. doi: 10.1093/jnci/djy171. Review.

21.

CD4+/CD8+ immunophenotype switching as a marker for intraocular and CNS involvement in mycosis fungoides.

Husnain M, Mackrides N, Vega F, Paez-Escamilla M, Markoe AM, Harbour JW, Lossos IS.

Leuk Lymphoma. 2019 May;60(5):1308-1311. doi: 10.1080/10428194.2018.1526376. Epub 2018 Nov 14. No abstract available.

PMID:
30424702
22.

Diagnosis of Bilateral Retinocytoma in an Adolescent Patient Using Multimodal Imaging and Genetic Testing.

Paez-Escamilla M, Walter SD, Ramaiya KJ, Harbour JW.

Ophthalmic Surg Lasers Imaging Retina. 2018 Oct 1;49(10):812-814. doi: 10.3928/23258160-20181002-11.

PMID:
30395669
23.

ChIPprimersDB: a public repository of verified qPCR primers for chromatin immunoprecipitation (ChIP).

Kurtenbach S, Reddy R, Harbour JW.

Nucleic Acids Res. 2019 Jan 8;47(D1):D46-D49. doi: 10.1093/nar/gky813.

24.

Are Risk Factors for Growth of Choroidal Nevi Associated With Malignant Transformation? Assessment With a Validated Genomic Biomarker.

Harbour JW, Paez-Escamilla M, Cai L, Walter SD, Augsburger JJ, Correa ZM.

Am J Ophthalmol. 2019 Jan;197:168-179. doi: 10.1016/j.ajo.2018.08.045. Epub 2018 Sep 7.

25.

Persistent fetal vasculature presenting with axial elongation and platyphakia.

Lin J, Paez-Escamilla M, Teira LE, Fallas B, Harbour JW.

J AAPOS. 2019 Feb;23(1):51-53. doi: 10.1016/j.jaapos.2018.06.005. Epub 2018 Aug 31.

PMID:
30176292
26.

Gene Expression Profiling and PRAME Status Versus Tumor-Node-Metastasis Staging for Prognostication in Uveal Melanoma.

Cai L, Paez-Escamilla M, Walter SD, Tarlan B, Decatur CL, Perez BM, Harbour JW.

Am J Ophthalmol. 2018 Nov;195:154-160. doi: 10.1016/j.ajo.2018.07.045. Epub 2018 Aug 6.

27.

Reduced BAP1 activity prevents ASXL1 truncation-driven myeloid malignancy in vivo.

Guo Y, Yang H, Chen S, Zhang P, Li R, Nimer SD, Harbour JW, Xu M, Yang FC.

Leukemia. 2018 Aug;32(8):1834-1837. doi: 10.1038/s41375-018-0126-9. Epub 2018 Apr 2. No abstract available.

28.

Congenital Hypertrophy of the Retinal Pigment Epithelium Presenting With Secondary Choroidal Neovascularization.

Garoon RB, Harbour JW.

Ophthalmic Surg Lasers Imaging Retina. 2018 Apr 1;49(4):276-277. doi: 10.3928/23258160-20180329-12.

PMID:
29664987
29.

Anterior Chamber Chemotherapy in Retinoblastoma-Necessary But Not Sufficient for Aqueous Seeding Control-Reply.

Harbour JW, Paez-Escamilla M.

JAMA Ophthalmol. 2018 May 1;136(5):597. doi: 10.1001/jamaophthalmol.2018.0639. No abstract available.

PMID:
29596550
30.

RETINOCYTOMA WITH VITREOUS SEEDING: NEW INSIGHTS FROM ENHANCED DEPTH IMAGING OPTICAL COHERENCE TOMOGRAPHY AND HIGH-RESOLUTION POSTERIOR SEGMENT ULTRASONOGRAPHY.

Garoon RB, Medina CA, Scelfo C, Harbour JW.

Retin Cases Brief Rep. 2018 Feb 21. doi: 10.1097/ICB.0000000000000732. [Epub ahead of print]

PMID:
29470300
31.

Retinoblastoma With Endophytic and Exophytic Features.

Paez-Escamilla M, Bagheri N, Harbour JW.

JAMA Ophthalmol. 2018 Jan 11;136(1):e175064. doi: 10.1001/jamaophthalmol.2017.5064. Epub 2018 Jan 11. No abstract available.

PMID:
29327048
32.

Punctuated evolution of canonical genomic aberrations in uveal melanoma.

Field MG, Durante MA, Anbunathan H, Cai LZ, Decatur CL, Bowcock AM, Kurtenbach S, Harbour JW.

Nat Commun. 2018 Jan 9;9(1):116. doi: 10.1038/s41467-017-02428-w.

33.

Familial and Somatic BAP1 Mutations Inactivate ASXL1/2-Mediated Allosteric Regulation of BAP1 Deubiquitinase by Targeting Multiple Independent Domains.

Peng H, Prokop J, Karar J, Park K, Cao L, Harbour JW, Bowcock AM, Malkowicz SB, Cheung M, Testa JR, Rauscher FJ 3rd.

Cancer Res. 2018 Mar 1;78(5):1200-1213. doi: 10.1158/0008-5472.CAN-17-2876. Epub 2017 Dec 28.

34.

Molecular Characteristics of Conjunctival Melanoma Using Whole-Exome Sequencing.

Swaminathan SS, Field MG, Sant D, Wang G, Galor A, Dubovy SR, Harbour JW, Karp CL.

JAMA Ophthalmol. 2017 Dec 1;135(12):1434-1437. doi: 10.1001/jamaophthalmol.2017.4837.

35.

Gain of function of ASXL1 truncating protein in the pathogenesis of myeloid malignancies.

Yang H, Kurtenbach S, Guo Y, Lohse I, Durante MA, Li J, Li Z, Al-Ali H, Li L, Chen Z, Field MG, Zhang P, Chen S, Yamamoto S, Li Z, Zhou Y, Nimer SD, Harbour JW, Wahlestedt C, Xu M, Yang FC.

Blood. 2018 Jan 18;131(3):328-341. doi: 10.1182/blood-2017-06-789669. Epub 2017 Nov 7.

36.

Letter to the Editor: Comparison of Alternative Tumor Size Classifications for Posterior Uveal Melanomas.

Harbour JW, Paez-Escamilla M.

Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5444. doi: 10.1167/iovs.17-22603. No abstract available.

PMID:
29059310
37.

Liquid Biopsy in Retinoblastoma.

Harbour JW.

JAMA Ophthalmol. 2017 Nov 1;135(11):1231. doi: 10.1001/jamaophthalmol.2017.4094. No abstract available.

PMID:
29049432
38.

Multimodal Imaging of Astrocytic Hamartomas Associated With Tuberous Sclerosis.

Schwartz SG, Harbour JW.

Ophthalmic Surg Lasers Imaging Retina. 2017 Sep 1;48(9):756-758. doi: 10.3928/23258160-20170829-11.

PMID:
28902337
39.

An international survey of classification and treatment choices for group D retinoblastoma.

Scelfo C, Francis JH, Khetan V, Jenkins T, Marr B, Abramson DH, Shields CL, Pe'er J, Munier F, Berry J, Harbour JW, Yarovoy A, Lucena E, Murray TG, Bhagia P, Paysse E, Tuncer S, Chantada GL, Moll AC, Ushakova T, Plager DA, Ziyovuddin I, Leal CA, Materin MA, Ji XD, Cursino JW, Polania R, Kiratli H, All-Ericsson C, Kebudi R, Honavar SG, Vishnevskia-Dai V, Epelman S, Daniels AB, Ling JD, Traore F, Ramirez-Ortiz MA.

Int J Ophthalmol. 2017 Jun 18;10(6):961-967. doi: 10.18240/ijo.2017.06.20. eCollection 2017.

40.

Fluorescein angiography findings in diffuse retinoblastoma: two case reports with clinicopathologic correlation.

Fernandez MP, Al-Holou SN, Fischer O, Murray T, Harbour JW, Dubovy SR, Berrocal AM.

J AAPOS. 2017 Aug;21(4):337-339.e2. doi: 10.1016/j.jaapos.2017.03.013. Epub 2017 Jul 8. Review.

PMID:
28694215
41.

Incorporating Clinical, Histological, and Genetic Parameters for Choroidal Melanoma Prognostication-Reply.

Harbour JW.

JAMA Ophthalmol. 2017 Jul 1;135(7):819-820. doi: 10.1001/jamaophthalmol.2017.1393. No abstract available.

PMID:
28542673
42.

PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.

Gezgin G, Luk SJ, Cao J, Dogrusöz M, van der Steen DM, Hagedoorn RS, Krijgsman D, van der Velden PA, Field MG, Luyten GPM, Szuhai K, Harbour JW, Jordanova ES, Heemskerk MHM, Jager MJ.

JAMA Ophthalmol. 2017 Jun 1;135(6):541-549. doi: 10.1001/jamaophthalmol.2017.0729.

43.

Preclinical Acute Ocular Safety Study of Combined Intravitreal Carboplatin and Etoposide Phosphate for Retinoblastoma.

Mohney BG, Elner VM, Smith AB, Harbour JW, Smith BD, Musch DC, Smith SJ.

Ophthalmic Surg Lasers Imaging Retina. 2017 Feb 1;48(2):151-159. doi: 10.3928/23258160-20170130-09.

PMID:
28195618
44.

ASXL1 interacts with the cohesin complex to maintain chromatid separation and gene expression for normal hematopoiesis.

Li Z, Zhang P, Yan A, Guo Z, Ban Y, Li J, Chen S, Yang H, He Y, Li J, Guo Y, Zhang W, Hajiramezanali E, An H, Fajardo D, Harbour JW, Ruan Y, Nimer SD, Yu P, Chen X, Xu M, Yang FC.

Sci Adv. 2017 Jan 20;3(1):e1601602. doi: 10.1126/sciadv.1601602. eCollection 2017 Jan.

45.

Prognostic Implications of the Largest Basal Tumor Diameter vs the TNM Staging System in Association With the Gene Expression Profile for Uveal Melanoma-Reply.

Harbour JW.

JAMA Ophthalmol. 2017 Feb 1;135(2):175-176. doi: 10.1001/jamaophthalmol.2016.5109. No abstract available.

PMID:
28056125
46.

Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas.

Field MG, Durante MA, Decatur CL, Tarlan B, Oelschlager KM, Stone JF, Kuznetsov J, Bowcock AM, Kurtenbach S, Harbour JW.

Oncotarget. 2016 Sep 13;7(37):59209-59219. doi: 10.18632/oncotarget.10962.

47.

An Iris Tumor.

Rao RC, Harbour JW.

JAMA Ophthalmol. 2016 Sep 1;134(9):1063-4. doi: 10.1001/jamaophthalmol.2016.0924. No abstract available.

48.

A rare case of leptomeningeal carcinomatosis in a patient with uveal melanoma: case report and review of literature.

Fedorenko IV, Evernden B, Kenchappa RS, Sahebjam S, Ryzhova E, Puskas J, McIntosh L, Caceres G, Magliocco A, Etame A, Harbour JW, Smalley KS, Forsyth PA.

Melanoma Res. 2016 Oct;26(5):481-6. doi: 10.1097/CMR.0000000000000274. Review.

49.

ARF6 Is an Actionable Node that Orchestrates Oncogenic GNAQ Signaling in Uveal Melanoma.

Yoo JH, Shi DS, Grossmann AH, Sorensen LK, Tong Z, Mleynek TM, Rogers A, Zhu W, Richards JR, Winter JM, Zhu J, Dunn C, Bajji A, Shenderovich M, Mueller AL, Woodman SE, Harbour JW, Thomas KR, Odelberg SJ, Ostanin K, Li DY.

Cancer Cell. 2016 Jun 13;29(6):889-904. doi: 10.1016/j.ccell.2016.04.015. Epub 2016 Jun 2.

50.

Prognostic Implications of Tumor Diameter in Association With Gene Expression Profile for Uveal Melanoma.

Walter SD, Chao DL, Feuer W, Schiffman J, Char DH, Harbour JW.

JAMA Ophthalmol. 2016 Jul 1;134(7):734-40. doi: 10.1001/jamaophthalmol.2016.0913.

Supplemental Content

Loading ...
Support Center